- Home
- GOLF vs MRUS Comparison
GOLF vs MRUS Comparison
Compare GOLF & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOLF
- MRUS
- Stock Information
- Founded
- GOLF 1910
- MRUS 2003
- Country
- GOLF United States
- MRUS Netherlands
- Employees
- GOLF N/A
- MRUS N/A
- Industry
- GOLF Recreational Games/Products/Toys
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- GOLF Consumer Discretionary
- MRUS Health Care
- Exchange
- GOLF Nasdaq
- MRUS Nasdaq
- Market Cap
- GOLF 4.2B
- MRUS 3.6B
- IPO Year
- GOLF 2016
- MRUS 2016
- Fundamental
- Price
- GOLF $71.35
- MRUS $44.36
- Analyst Decision
- GOLF Buy
- MRUS Strong Buy
- Analyst Count
- GOLF 5
- MRUS 10
- Target Price
- GOLF $71.40
- MRUS $86.70
- AVG Volume (30 Days)
- GOLF 359.0K
- MRUS 434.2K
- Earning Date
- GOLF 11-07-2024
- MRUS 10-31-2024
- Dividend Yield
- GOLF 1.21%
- MRUS N/A
- EPS Growth
- GOLF N/A
- MRUS N/A
- EPS
- GOLF 2.93
- MRUS N/A
- Revenue
- GOLF $2,424,883,000.00
- MRUS $35,932,000.00
- Revenue This Year
- GOLF $5.42
- MRUS N/A
- Revenue Next Year
- GOLF $3.74
- MRUS $52.49
- P/E Ratio
- GOLF $24.34
- MRUS N/A
- Revenue Growth
- GOLF 0.35
- MRUS N/A
- 52 Week Low
- GOLF $55.75
- MRUS $22.26
- 52 Week High
- GOLF $76.38
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- GOLF 66.85
- MRUS 32.24
- Support Level
- GOLF $67.59
- MRUS $42.30
- Resistance Level
- GOLF $69.68
- MRUS $53.49
- Average True Range (ATR)
- GOLF 2.23
- MRUS 2.29
- MACD
- GOLF 0.32
- MRUS -1.04
- Stochastic Oscillator
- GOLF 65.39
- MRUS 15.70
About GOLF Acushnet Holdings Corp.
Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, of which key revenue is derived from the sales of golf balls and golf gloves. The operating segments of the company are Titleist golf balls, Titleist golf clubs, Titleist golf gear and FootJoy golf wear. Geographically, the company operates in the United States, EMEA, Japan, Korea and other countries, of which a majority of the revenue is generated from the operations in the United States.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.